By Rev Shark
RealMoney.com Contributor
1/21/2010 8:06 AM EST
Excess generally causes reaction, and produces a change in the opposite direction, whether it be in the seasons, or in individuals, or in governments.
-- Plato
The fourth-quarter earnings reports we have seen so far have been quite positive, but the market reaction has been quite poor. We had a sharp jump on Tuesday, but that was driven by speculation over the Massachusetts election rather than earnings reports. Good news from the likes of Intel (INTC) and IBM (IBM) have been sold and the broad market indices have been under pressure. We have had better action in the financials as they have reported, but it's mainly smaller regional banks that are acting the best.
The Obama administration's primary response to the shocking election loss in Massachusetts has been to shift the focus of debate to banks and Wall Street. A set of proposals that will restrict the size of banks and put limits on trading is expected. Bank of America (BAC) , Wells Fargo (WFC) , JPMorgan (JPM) , Morgan Stanley (MS) , Citigroup (C) and Goldman Sachs (GS) are all expected to be affected by the new rules.
There are some very good arguments for these rules, but my concern is that the anti-Wall Street efforts will spill over and hurt market players who were victims rather than perpetrators of the reckless excesses that helped cause many or our economic problems. The financial industry is such an easy target for politicians that chances of collateral damage are quite high.
We are very likely to see anti-Wall Street rhetoric build. So far it has not had any negative impact on market action, but the fact that the market has acted so well for so long just makes it a better target for politicians who want to fan the flames of class warfare.
Of more immediate concern is earnings season. We have Goldman coming up this morning and then Google (GOOG) tonight. It is going to be very interesting to see if these stocks, which have been struggling a bit lately, suffer from a "sell the news" reaction like Intel and IBM saw. Both of those stocks were very strong into their reports so the setup is quite different.
The reaction to these key reports is extremely important because the overall technical picture is starting to show some cracks. We are still just barely off recent highs, but we have seen some distribution as we have sold off on higher volume. We bounced back late in the day on Wednesday, which helped, but the selling squalls have been more intense than we have seen in a while.
We still have not suffered any really notable breakdowns, but there is an absence of any strong market leadership. China stocks, which were the hottest momentum sector for a while, have slowed considerably on news of attempts by the Chinese central banks to cool things off. Other hot groups like solar energy and bulk shipping have cooled off as well.
The dollar has rallied to its highest levels since early September, and that is putting considerable pressure on oil, gold, steel and commodity sectors that led us for much of the last three months.
Technology stocks have had some good earnings reports, but they have not been able to gain any notable upside traction. Financials have had the best performance lately but they aren't exactly flying.
We'll see how it goes as earnings reports come out. The news has been pretty good but the reactions haven't been. If that theme continues, we will need to boost our defensive efforts.
-----------------------------
Ülespoole avanevad:
In reaction to strong earnings/guidance: STX +12.6%, EBAY +8.0%, FCS +6.9%, PLXS +6.8% (also upgraded to Buy at Needham), FITB +6.6%, EL +6.1%, PNRA +4.4%, KEY +4.3%, FFIV +4.0% (also upgraded to Buy at BofA/Merrill), DOX +3.8% (also upgraded to Buy at BofA/Merrill), UNH +3.6% (light volume), SBUX +3.5% (also upgraded to Buy at Deutsche), XRX +3.3%, NITE +2.8%, CAL +2.8%, LUV +2.4%, GS +1.0%... Other news: STKL +15.5% (signs contract with major ethanol producer in China), WDC +3.9% and SNDK +2.5% (trading up in sympathy with STX), AUXL +3.2% (Auxilium Pharma and Pfizer announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contractur), STEC +2.5% (rebounding from yesterday's 10%+drop), SCHW +1.5% (prices 26.316 mln common share offering at $19.00/share), APC +1.4% (announces the Tweneboa-2 appraisal well, offshore Ghana, encountered more than 105 feet of net pay in stacked reservoir sands), ORCL +1.0% (European Commission unconditionally approves Oracle's acquisition of Sun)... Analyst comments: AAI +2.6% (upgraded to Buy from Sell at Argus),PPO +2.4% (upgraded to Outperform from Market Perform at William Blair), CL +1.8% (added to Conviction Buy List at Goldman), SYMC +1.0% (upgraded to Outperform from Neutral at Macquarie).
Allapoole avanevad:
In reaction to disappointing earnings/guidance: BBI -31.5% (also downgraded to Neutral at Janney), TSS -14.2%, LM -6.6%, SVA -4.5% (also announces offering of 8,650,000 Common Shares), SWKS -3.5%, WGOV -2.2% (light volume), KMP -1.5% (light volume), FCX -1.0%... Select financials showing weakness: RBS -4.0%, BCS -3.9%, NBG -3.2% (Greece not seeking aid to plug debt hole - AP), STD -2.5%, LYG -2.4%, RY -1.7%, DB -1.0%... Select metals/mining names trading lower: RTP -4.1%, SLW -2.2%, GFI -2.2%, BBL -1.8%, MT -1.8%, BHP -1.7%, GOLD -1.5%, AUY -1.3%, AU -1.1%, SLV -0.9%... Other news: ISPH -20.0% (announces results of phase 3 PROLACRIA trial for dry eye), CAMP -7.9% (files for ~2.4 mln share common stock offering by selling stockholders), GRMN -5.9% (Nokia releases new version of Ovi Maps for smartphones at no extra cost), AMAG -1.0% (prices 3.6 mln common shares at $48.25/share)... Analyst comments: PCX -3.6% (downgraded to Sell at Citigroup), MEE -3.0% (downgraded to Sell at Citigroup), CNX -2.5% (downgraded to Hold at Citigroup), ACI -2.4% (downgraded to Sell at Citigroup), MET -2.3% (downgraded to Neutral from Buy at BofA/Merrill), PRU -1.3% (downgraded to Hold from Buy at Citigroup), BSX -1.2% (downgraded to Market Perform from Outperform at Bernstein), MS -0.8% (downgraded to Mkt Perform at Keefe, Bruyette).
December Leading Indicators +1.1% vs +0.7% consensus, prior revised to +1.0% from +0.9%
Piladelphia Fedi äriväljavaadete küsitluse oodatust nõrgemaid tulemusi võib seostada viimase tunni aja nõrkusega.
Maagaasivarud jätkavad külma talve, madala pakkumise ja taastuva tööstusnõudluse tõttu kiiret vähenemist:
Natural gas inventory showed a draw of 245 bcf, analysts were expecting a draw of 230 bcf, with ests ranging from a draw of 255 bcf to a draw of 198 bcf.
Panen siia taaskord graafiku maagaasivarude kohta, kus punane joon näitab praeguseid varusid ning hall vahemik 5 aasta miinimum ja maksimumvarusid. Viimase nädala varude vähenemine tõi praegused varud viimase 5 aasta keskmise võrdluses juba 0.2% keskmisest allapoole. Suured ülejäägid varudes on likvideeritud väga lühikese ajaga. Suurema gaasitarbimisega ida-osariikides on praegused varud keskmisest juba 3.8% allpool.
Obama proposes to limit bank proprietary trading
Pangad saavad kõige rohkem pihta, kuid siin on üks artikkel, mile kohaselt Goldman Sachsi see uudis ei pruugigi puudutada: http://ftalphaville.ft.com/blog/2010/01/21/131501/whither-goldmans-prop-desk/
See Obama trikk ilmselt annab veel pikemat aega valusalt tunda, ei tea peaks positsiooni likvideerima. Kasum ja kahjum null, a ikkagi see raha oleks teenind Tallinnas head kasumit. Närvi ajab see Obama
Jahutud ju küll, et midagi tuleb ette võtta ja nurisetud, et selles suunas on tehtud vähe tööd. Nüüd, kus hakatakse liigutama, on kõik jama?
Pangad keetsid selle supi kokku, mis toimus. Ju on märkke, et keedetakse riigi rahadega uut kisselli, mida keegi hiljem ära ei jõua süüa.
Poliitik peab rahvale näitama, et pangad lihtsalt ei pääse.
Kõik pangad ei põhjustanud seda jama, kuid TARP raha sunniti kõik võtma. Nüüd karistatakse neid selle eest, et TARP raha võtsid.
btw, müüsin täna BAC ja C ja ostsin GS juurde.
Too big to fail oli aasta tagasi põhi jutt ja nüüd tuleb välja, et tegelikult ei olnud?